1. Home
  2. ALH vs BLTE Comparison

ALH vs BLTE Comparison

Compare ALH & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alliance Laundry Holdings Inc.

ALH

Alliance Laundry Holdings Inc.

HOLD

Current Price

$21.27

Market Cap

5.1B

Sector

Industrials

ML Signal

HOLD

Logo Belite Bio Inc

BLTE

Belite Bio Inc

HOLD

Current Price

$147.91

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALH
BLTE
Founded
1908
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1B
6.0B
IPO Year
2025
2021

Fundamental Metrics

Financial Performance
Metric
ALH
BLTE
Price
$21.27
$147.91
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
9
Target Price
$31.13
★ $228.89
AVG Volume (30 Days)
★ 924.4K
133.0K
Earning Date
11-12-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
★ 0.62
N/A
Revenue
★ $1,709,237,000.00
N/A
Revenue This Year
$6.64
N/A
Revenue Next Year
$6.19
N/A
P/E Ratio
$34.61
★ N/A
Revenue Growth
★ 13.31
N/A
52 Week Low
$18.64
$90.84
52 Week High
$28.23
$200.00

Technical Indicators

Market Signals
Indicator
ALH
BLTE
Relative Strength Index (RSI) 45.10 39.67
Support Level $20.82 $145.21
Resistance Level $22.07 $161.08
Average True Range (ATR) 0.55 5.89
MACD 0.10 -0.37
Stochastic Oscillator 57.62 30.70

Price Performance

Historical Comparison
ALH
BLTE

About ALH Alliance Laundry Holdings Inc.

Alliance Laundry Holdings Inc is a designer and manufacturer of commercial laundry systems, serving diverse international markets. The company offers premium, durable laundry equipment under brands like Speed Queen, UniMac, Huebsch, Primus, IPSO, and others. It serves commercial laundry needs across healthcare, hotels, laundromats, and residential markets. Revenue is generated through the sale of commercial-grade laundry systems and service parts across two geographic segments, North America and International, and into the three end markets of OPL, Vended, and Commercial In-Home.

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.

Share on Social Networks: